95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.50%
Negative revenue growth while OR stands at 9.92%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.30%
Negative gross profit growth while OR is at 10.18%. Joel Greenblatt would examine cost competitiveness or demand decline.
-5.62%
Negative EBIT growth while OR is at 15.15%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-5.62%
Negative operating income growth while OR is at 7.56%. Joel Greenblatt would press for urgent turnaround measures.
-16.06%
Negative net income growth while OR stands at 26.20%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-10.00%
Negative EPS growth while OR is at 21.43%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11.11%
Negative diluted EPS growth while OR is at 21.43%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.34%
Share count expansion well above OR's 0.41%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.70%
Diluted share count expanding well above OR's 0.35%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-2.65%
Negative OCF growth while OR is at 11.49%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-2.65%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
141.24%
10Y revenue/share CAGR at 50-75% of OR's 191.83%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
124.47%
5Y revenue/share CAGR above 1.5x OR's 29.95%. David Dodd would look for consistent product or market expansions fueling outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
40.43%
Below 50% of OR's 192.29%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-7.79%
Negative 3Y OCF/share CAGR while OR stands at 22738.42%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
622.91%
5Y net income/share CAGR above 1.5x OR's 117.59%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
229.95%
3Y net income/share CAGR above 1.5x OR's 86.14%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
874.54%
Positive growth while OR is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
1188.92%
Positive 5Y equity/share CAGR while OR is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-88.33%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-13.81%
Firm’s AR is declining while OR shows 8.62%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
60.34%
Asset growth above 1.5x OR's 3.85%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.70%
Under 50% of OR's 5.86%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.06%
We cut SG&A while OR invests at 19.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.